Business Continuity Measures for COVID-19
First written in FY2020. 10 of 11 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2026: 2 of 7 companies on the "Worse" side.
- FY2024RestatedAnnual report
「Regarding COVID-19, which became a pandemic, the company implemented measures through its Risk Management Committee and worked to prevent infection, including reducing opportunities for contact by having employees work from home or use staggered working hours, except for the minimum personnel required to maintain business continuity. The company will continue working to maintain business operations in order to fulfill its social mission of ensuring a stable supply of pharmaceuticals.」
The company continues measures by its Risk Management Committee, working from home and staggered working hours, and efforts to maintain business operations. - FY2023-Q3RestatedAnnual report
「As part of its response to COVID-19, the company worked to prevent infection, including reducing opportunities for contact by having employees work from home or use staggered working hours, except for the minimum personnel required to maintain business continuity. Although the situation remains unpredictable, the company will continue working to maintain business operations in order to fulfill its social mission of ensuring a stable supply of pharmaceuticals.」
The company continues efforts to reduce opportunities for contact through working from home and staggered working hours, and to maintain business operations aimed at ensuring a stable supply of pharmaceuticals. - FY2023-Q2RestatedAnnual report
「As part of its response to COVID-19, the company worked to prevent infection, including reducing opportunities for contact by having employees work from home or use staggered working hours, except for the minimum personnel required to maintain business continuity. Although the situation remains unpredictable, the company will continue working to maintain business operations in order to fulfill its social mission of ensuring a stable supply of pharmaceuticals.」
The company continues efforts to reduce opportunities for contact through working from home and staggered working hours, and to maintain business operations aimed at ensuring a stable supply of pharmaceuticals. - FY2023-Q1RestatedAnnual report
「As part of its response to COVID-19, the company worked to prevent infection, including reducing opportunities for contact by having employees work from home or use staggered working hours, except for the minimum personnel required to maintain business continuity. Although the situation remains unpredictable, the company will continue working to maintain business operations in order to fulfill its social mission of ensuring a stable supply of pharmaceuticals.」
The company continues efforts to reduce opportunities for contact through working from home and staggered working hours, and to maintain business operations aimed at ensuring a stable supply of pharmaceuticals. - FY2022RestatedAnnual report
「Regarding COVID-19, which became a pandemic, the company implemented measures through its Risk Management Committee and worked to prevent infection, including reducing opportunities for contact by having employees work from home or use staggered working hours, except for the minimum personnel required to maintain business continuity. Although the situation remains unpredictable, the company will continue working to maintain business operations in order to fulfill its social mission of ensuring a stable supply of pharmaceuticals.」
The company continues measures by its Risk Management Committee, working from home and staggered working hours, and efforts to maintain business operations. - FY2022-Q2RestatedAnnual report
「As part of its response to COVID-19, the company worked to prevent infection, including reducing opportunities for contact by having employees work from home or use staggered working hours, except for the minimum personnel required to maintain business continuity. Although the situation remains unpredictable, the company will continue working to maintain business operations in order to fulfill its social mission of ensuring a stable supply of pharmaceuticals.」
The company continues efforts to reduce opportunities for contact through working from home and staggered working hours, and to maintain business operations aimed at ensuring a stable supply of pharmaceuticals. - FY2021RestatedAnnual report
「Regarding COVID-19, which became a pandemic, the company implemented measures through its Risk Management Committee and worked to prevent infection, including reducing opportunities for contact by having employees work from home or use staggered working hours, except for the minimum personnel required to maintain business continuity. Although the situation remains unpredictable, the company will continue working to maintain business operations in order to fulfill its social mission of ensuring a stable supply of pharmaceuticals.」
The company continues measures by its Risk Management Committee, working from home and staggered working hours, and efforts to maintain business operations. - FY2021-Q3RestatedAnnual report
「As part of its response to COVID-19, the company worked to prevent infection, including reducing opportunities for contact by having employees work from home or use staggered working hours, except for the minimum personnel required to maintain business continuity. Although the situation remains unpredictable, the company will continue working to maintain business operations in order to fulfill its social mission of ensuring a stable supply of pharmaceuticals.」
The company continues efforts to reduce opportunities for contact through working from home and staggered working hours, and to maintain business operations aimed at ensuring a stable supply of pharmaceuticals. - FY2021-Q2RestatedAnnual report
「As part of its response to COVID-19, the company worked to prevent infection, including reducing opportunities for contact by having employees work from home or use staggered working hours, except for the minimum personnel required to maintain business continuity. Although the situation remains unpredictable, the company will continue working to maintain business operations in order to fulfill its social mission of ensuring a stable supply of pharmaceuticals.」
The company continues efforts to reduce opportunities for contact through working from home and staggered working hours, and to maintain business operations aimed at ensuring a stable supply of pharmaceuticals. - FY2021-Q1RestatedAnnual report
「As part of its response to COVID-19, the company worked to prevent infection, including reducing opportunities for contact by having employees work from home or use staggered working hours, except for the minimum personnel required to maintain business continuity. Although the situation remains unpredictable, the company will continue working to maintain business operations in order to fulfill its social mission of ensuring a stable supply of pharmaceuticals.」
In response to COVID-19, the company continues efforts to reduce opportunities for contact through working from home and staggered working hours, and to maintain business operations. - FY2020First statedAnnual report
「Regarding COVID-19, which became a pandemic, the company implemented measures through its Risk Management Committee and worked to prevent infection, including reducing opportunities for contact by having employees work from home or use staggered working hours, except for the minimum personnel required to maintain business continuity.」
The company states that it implemented measures through its Risk Management Committee in response to COVID-19 and worked to reduce opportunities for contact through working from home, staggered working hours and other measures.